Susann Bellmann

Chief Technology Officer

InnoGI Technology (formerly known as The TIM Company)

Susann Bellmann is the Chief Technology Officer (CTO), member of the Top Management Team at InnoGI Technology (formerly known as The TIM Company). She is a subject matter expert in gastrointestinal research and oversees the R&D department at Inno GI Technologies.

Her research is related to predictive in vitro performance testing of oral formulations as an alternative to animal studies.

Susann Bellmann is a certified professional in strategic business marketing and a proven Project Manager with over 10 years of demonstrated leadership skills. The relevance and success of her projects are documented in many peer-reviewed publications, conference presentations, and technical reports.

To advance the field of in vitro gastrointestinal research, she has initiated the TIM Pharmaceutical Expert Working Group, with recurring symposia (last year for the 8th time), which brings together international scientists to discuss late-stage preclinical formulation development and performance testing. An important goal of this initiative is the contribution to reducing and replacing animal studies, i.e., preclinical dog studies, and to engage with regulators in a dialogue for the use of innovative in vitro techniques to finetune and de-risk clinical trials.